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Abstract 
This paper examines the Global publications on hepatitis C research during 2009-2018. This study aims to 
analyze the hepatitis c research publications, carried out by using the Scopus online database during the period of 
ten years from 2009 to 2018. From this study find out the year wise growth of publications, country, author, 
organization, document type, language-wise publications, and citation analysis and identified the impact factor 
(IF) of the journal productivity in the field of hepatitis C research. 
 During the ten year study period, it identified that 59926 publications contributed to the field of hepatitis C 
research. During the period, RGR is 0.71 to 0.10 and correspondingly the doubling time (Dt) is 0.98 to 7.28. 
Maximum of 41141 (68.65%) research publications are articles, and 55746 research publications are the English 
Language. Maximum of 18160 (23.10%) publications contributed by the United States and the relative citation 
index is varied from 0.95 to 3.3.  
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Introduction 
A disease is the biggest task to solve in this world to survive for the human begins, day by day the new infections 
are occupying in the human body.  Diseases won’t see the human to affect by global, regional, and national age-
sex, etc., some disease is curable, some cause to death and some are unable to identify this may be due to the lack 
of facility available in the health.  As per the 2016 data of World Health Organization  54% (i.e., more than half 
%) death were due to the top 10 causes of diseases worldwide. ,  These diseases have remained in the last 15 
years for leading causes of death globally and were classified into three types (i) Communicable, maternal, per 
natal and nutritional conditions (ii) Noncommunicable diseases and (iii)Injuries [1]. Hepatitis is one of the types 
of disease causes to death worldwide.  Global Burden of Diseases study updated on 2015 and ranked chronic viral 
hepatitis and its underlying conditions, among the top 20 causes of death caused by cirrhosis and liver cancer, and 
it's increasing steeply from 1990 to 2015 [2]. 
Since 2000, global public health stakeholders have increasingly recognized viral hepatitis as a major cause of 
death. In 2015, WHO’s Global Health Estimates [GHE] indicated that acute liver failure, cirrhosis and 
hepatocellular carcinoma secondary to viral hepatitis lead to more deaths, and it has been increasing worldwide 
than the human immunodeficiency virus [HIV], tuberculosis [TB] or malaria and also the data shows that in 2015, 
29.7% of hepatitis deaths were attributable to infection with HCV [3]. According to Stedman’s Medical 
Dictionary “Hepatitis is an inflammation of the liver, due usually to viral infection but sometimes to toxic agents. 
Previously endemic throughout much of the developing world, viral Hepatitis now ranks as a major public health 
problem in industrialized nations. The three most common type of viral Hepatitis were (A, B, and C) affects 
millions worldwide” [4]. 
Hepatitis C is a liver infection; most of them don’t know the symptoms, but it causes few symptoms by the 
hepatitis C virus.[5]  Hepatitis C found worldwide. Hepatitis C virus infection can be determined in certain 
populations it depends on the country, (for example people who inject drugs) and/or in general populations. [6] 
The World Health Organization (WHO) has stated by the year 2030 viral hepatitis will be eliminated as a public 
health threat. Global burden of hepatitis C virus (HCV) currently estimated at 71 million people [7]. The key 
recommendations and the elimination goals of WHO are to reduce new infections by 90% and HCV-related liver 
mortality by 65% [8].    
Literature Review 
Sangam et. al. (2018)9 have examined by collecting data from PubMed and the Web of Science (WoS) for the 
period 1976-2015 to find out the hepatitis literature in the world and its growth. The result shows in India that the 
cumulative number of publications doubled in the year 2008 and the publications were significantly increased. 
Schmidt et. al.  (2014)10 focused on hepatitis B in his paper, he compares the research articles published in USA 
and Europe countries with the countries of China and Taiwan, Pubmed and ISI‐Web used for research data for the 
period of 1971-2011. He examined that most productive supplier is the USA and the top ten ranking in most 
productivity authors in the field of publishing hepatitis B articles worldwide is China and Taiwan. Miri, Raoofi 
and Heidari (2012)11 carried out the citation analysis of Hepatitis monthly Journal, for his bibliometric study he 
used three databases (Web of Science, Google Scholar, and Scopus) among these three databases there is showing 
difference in the Impact Factor and also stated that publications of all articles never succeed to record. 
Trapero Marugán et. al. (2002)12, analyzed Spanish hospitals about the hepatitis C virus publications for the 
period 1980 to 2002. He used the Medline database to collect the data, he stated in his analysis that in 1980 no 
articles were published and in 1998 there were 121 articles published, and it decreased to 36 in 2002, while 
comparing to international journals articles Spanish journals published fewer articles related to hepatitis C Virus. 
Siva, Vivekanandhan and Manickraj (2018)13 analyze the digital library research publications in a 
scientometric analysis, which indexed in SCOPUS database, the period is between 2008 and 2017 with 10345 
publications. The average degree of collaboration is 0.78, the relative growth rate is decreasing trend and 
doubling time is increasing trend.  The United States ranked first with 2650 (25.62%) publications, and Giles C.L. 
stands with highest of 59 (0.57%) publications with 643(1.35%) citations and the h-index is 15. 
 
Objective of the study 
The main objectives of the studies are, 
• To study the year wise growth of research publication in Hepatitis C. 
• To analysis the relative growth rate and doubling time 
• To study the type of document in hepatitis C research publications 
• To examine the Language wise hepatitis C research publications 
• To analysis the top 15 most productive countries, share and RCI 
• To identify the top 15 most productive authors in Hepatitis C 
• To examine the top 15 Journals and Organizations contributions.  
 
Methodology 
The Hepatitis C research publications are identified during the period from 2009 to 2018 were determined using 
the Scopus database. Using the following search Keyword (TITLE-ABS-KEY("hepatitis C") AND PUBYEAR > 
2008 AND PUBYEAR < 2019.  h-index and relative citation index are calculated for this study.   The data was 
collected for this study is 20.02.2019.  During the ten year study period 59926 research publications are identified 
and analyses the relative growth rate and doubling time of the study, document type and top 15 countries, authors, 
journals and institutions. 
Data Analysis and Interpretations 
Year Wise Growth of Publications  
Table 1 shows that year wise growth of research publications in hepatitis C during the ten year study period 
between 2009 and 2018 with 59926 research publications. From the study, it identified that the maximum of 6547 
(10.93%) publications in the year 2015, followed by 6482 (10.82%) publications in the year 2014 and 6302 
(10.52%) publications in 2016. The average research publications for the ten year study period are 5992 
publications. Last ten years hepatitis C studies are identified from 8.76% to 10.93% of research contributions. 
Table 1 Year wise growth of Publications in hepatitis C 
S. 
No 
Year Publications % Cum. Cum. % 
1 2009 5251 8.76 5251 8.76 
2 2010 5396 9.00 10647 17.77 
3 2011 5886 9.82 16533 27.59 
4 2012 6155 10.27 22688 37.86 
5 2013 6301 10.51 28989 48.38 
6 2014 6482 10.82 35471 59.19 
7 2015 6547 10.93 42018 70.12 
8 2016 6302 10.52 48320 80.64 
9 2017 6168 10.29 54488 90.93 
10 2018 5438 9.07 59926 100.01 
Total 59926 100.00  
Relative Growth Rate and Doubling Time 
Relative Growth Rate (RGR)  
The most important features of science and technology in recent years are calculated by the rate of growth. 
Scientific growth involved not only increase in the man power and financial investment. The relative growth rates 
are identified by the increase in the number of publications per unit of time.  The mean relative growth rate over 
the particular period of an interval can be calculated in the following formula developed by Mahapatra (1985)14  
R(a) = (W2 - W1) / (T2 − T1) 
 Where, R(a) = RGR  = the mean relative  growth rate over the specific period of interval  
W1 = the logarithm of the beginning number of publications/pages  
W2= the logarithm of ending number of publications/pages after a specific period of interval  
T2 – T1 = the unit difference between the beginning time and the ending time. 
Here the year can think about the unit of time. The relative growth rate for both publications and pages are 
calculated separately.  
R(a) = Relative growth rate per unit of publications per unit of time  
R(p) = Relative growth rate per unit of pages per unit of time  
Doubling Time [Dt]  
The doubling time is the time taken for the doubling of the number of records published within a stipulated 
period. The doubling time is calculated from the relative growth rate (the difference between the logarithms of 
beginning and end of the year from the study), and the natural logarithm number is used, the difference has a 
value of 0.693. Thus the corresponding doubling time for each specific period of interval and both publications 
and pages can be calculated by the following formula,  
Dt = 0.693/ R(a) 
 
Table 2 Year wise Relative Growth Rate and Doubling Time in Hepatitis C 
S. No Year Publications Cum. W1 W2 
RGR = 
(W2-W1) 
Dt = 
(0.693/RGR) 
1 2009 5251 5251 0.00 8.57 0  
2 2010 5396 10647 8.57 9.27 0.71 0.98 
3 2011 5886 16533 9.27 9.71 0.44 1.57 
4 2012 6155 22688 9.71 10.03 0.32 2.19 
5 2013 6301 28989 10.03 10.27 0.25 2.83 
6 2014 6482 35471 10.27 10.48 0.20 3.43 
7 2015 6547 42018 10.48 10.65 0.17 4.09 
8 2016 6302 48320 10.65 10.79 0.14 4.96 
9 2017 6168 54488 10.79 10.91 0.12 5.77 
10 2018 5438 59926 10.91 11.00 0.10 7.28 
Total 59926      
From table 2, shows that RGR has been decreasing trend from (0.71) in the year 2009 to  (0.10) in the year 2018. 
Correspondingly the doubling time (Dt) has been increasing from 0.98 in the year 2010 to 7.28 in the year 2018. 
Type of Document in Hepatitis C Research Publications 
During the ten year study period on hepatitis C, research publications are identified from table 3. From the table 3 
maximum of 41141 (68.65%) research publications are contributed by the article, followed by 8850 (14.77%) 
research publications are reviewed, 3310 (5.52%) research publications are a letter, etc. 
Table 3 Document Type wise Publications in Hepatitis C 
S. No Document Type Publications % 
1 Article 41141 68.65 
2 Review 8850 14.77 
3 Letter 3310 5.52 
4 Note 2068 3.45 
5 Editorial 1768 2.95 
6 Conference Paper 906 1.51 
7 Book Chapter 807 1.35 
8 Short Survey 725 1.21 
9 Erratum 289 0.48 
10 Book 46 0.08 
11 Conference Review 13 0.02 
12 Retracted 3 0.01 
Total 59926 100.00 
This study confirmed that more than 83% of publications are contributed by article and review. From this study, it 
is identified that Less than 2% of contributions are conference paper, book chapter, short survey, erratum, book, 
conference review and retracted.  
Language wise Hepatitis C Research Publications 
Table 4 Language wise Publications in Hepatitis C 
 Number of Publications Share of Publications 
Language 2009-2013 2014-2018 2009-2018 2009-2013 2014-2018 2009-2018 
English 26363 29383 55746 89.64 93.77 91.77 
Spanish 489 304 793 1.66 0.97 1.31 
German 398 324 722 1.35 1.03 1.19 
Chinese 438 281 719 1.49 0.90 1.18 
French 399 240 639 1.36 0.77 1.05 
Japanese 290 258 548 0.99 0.82 0.90 
Russian 203 206 409 0.69 0.66 0.67 
Portuguese 127 46 173 0.43 0.15 0.28 
Polish 134 32 166 0.46 0.10 0.27 
Turkish 95 55 150 0.32 0.18 0.25 
Czech 56 37 93 0.19 0.12 0.15 
Italian 59 23 82 0.20 0.07 0.13 
Hungarian 47 30 77 0.16 0.10 0.13 
Croatian 49 25 74 0.17 0.08 0.12 
Korean 40 18 58 0.14 0.06 0.10 
Others 222 73 295 0.75 0.23 0.49 
Total 29409 31335 60744 100.00 100.00 100.00 
Language-wise research publications are identified in two five years block.  From table 4, it is identified that 
29409 research publications are contributed in the first block years of 2009 – 2013. Out of that, the maximum of 
26363 publications are the English language, followed by 489 publications are Spanish, 438 publications are 
Chinese, etc. From the 2nd block years of 2014 – 2019 identified that 31335 research publications. Out of that, 
the maximum of 29383 publications are the English language, followed by 324 publications are German, 304 
publications are Spanish, etc. From the overall ten year study period identified that maximum of 55746  
(91.77%)research publications are the English language, followed by 793 (1,31%) publications are Spanish, 722 
(1.19%)publications are German, etc.    
Global Publication Share and Citations of Top 15 Most Productive Countries 
Relative citation index (RCI) was developed by the Institute of Scientific Information (now Thomson Reuters, 
USA) and examined the impact of different countries and institutions in the field of Pollution Control research 
publications. The scientific impact of leading countries is analyzed by using two relative indicators, namely 
citations per paper (CPP) and relative citations index (RCI). Citations per paper (CPP) is a relative indicator 
computed as the average number of citation per paper. It has been broadly used into the bibliometric studies as it 
normalizes a large difference in the volumes of publications among most productive countries, institutions, and 
authors. To measure both, influence and visibility of country research in global wise, the following formula has 
been used by Bharvi Dutt and Khaiser Nikam (2016)15  
 
RCI= A Country share of the World Citations / A Country share of the World Publications 
Here 
RCI = 1 indicates that a country’s citation rate is equal to the world citation rate  
RCI > 1 indicates that a country’s citation rate is greater than the world citation rate  
RCI < 1 indicates that a country’s citation rate is lower than the world citation rate  
 CPP=Total Citations /Total Publications 
Table 5 Country wise Publications in Hepatitis C 
S. 
No 
Country Name 
Number of Publications Share of Publications 
TC % CPP RCI 2009-
2013 
2014-
2018 
2009-
2018 
2009-
2013 
2014-
2018 
2009-
2018 
1 United States 8545 9615 18160 23.50 22.76 23.10 460751 48.96 25.37 2.12 
2 Italy 2252 2410 4662 6.19 5.70 5.93 102637 10.91 22.02 1.84 
3 Japan 2313 2172 4485 6.36 5.14 5.70 73018 7.76 16.28 1.36 
4 China 1533 2299 3832 4.22 5.44 4.87 54146 5.75 14.13 1.18 
5 France 1952 1879 3831 5.37 4.45 4.87 114535 12.17 29.90 2.5 
6 UnitedKingdom 1829 1980 3809 5.03 4.69 4.84 106002 11.26 27.83 2.33 
7 Germany 1790 1804 3594 4.92 4.27 4.57 107593 11.43 29.94 2.5 
8 Spain 1548 1536 3084 4.26 3.64 3.92 74590 7.93 24.19 2.02 
9 Canada 1037 1334 2371 2.85 3.16 3.02 72018 7.65 30.37 2.54 
10 Australia 904 1159 2063 2.49 2.74 2.62 56138 5.97 27.21 2.27 
11 Egypt 774 1149 1923 2.13 2.72 2.45 21769 2.31 11.32 0.95 
12 Taiwan 709 862 1571 1.95 2.04 2.00 31762 3.38 20.22 1.69 
13 India 581 896 1477 1.60 2.12 1.88 19325 2.05 13.08 1.09 
14 Brazil 659 805 1464 1.81 1.91 1.86 21149 2.25 14.45 1.21 
15 Switzerland 538 671 1209 1.48 1.59 1.54 47712 5.07 39.46 3.3 
16 Others 9405 11683 21088 25.86 27.65 26.82     
Total 28989 30937 78623 100.00 100.00 100.00 941034    
 Table 5 shows that block year wise top 15 countries research publications, share, citations, CPP and RCI for 
hepatitis C research publications during 2009-18.  The publications contribution of top 15 most productive 
countries and others in hepatitis C was identified during 2009-18, which increased from 1st block year 2009-13 
with 28989 publications to 2nd block year 2014 - 2018 with 30937 publications. Individually, the global 
publication share of these 15 countries varied from 1.54% to 23.10% during 2009-18, with highest contribution 
share of  18160 (23.10%) publications with 460751 citations, CPP is 25.37and RCI is 2.12 by the United States, 
followed by Italy 4662 (5.93%) publications with 102637 citations, CPP is 22.02 and RCI is 1.81, Japan 
4485(5.70%) publications with 73018 citations, CPP is 16.28 and RCI is 1.36, China 3832(4.87%) publications 
with 54146 citations, CPP is 14.13 and RCI is 1.18  etc. 
During the study period the global publications share has been increased from 1st block years to 2nd block years by 
1.23% in China, Egypt (0.59%), India (0.52%), etc. And the same time decreased by 1.22% by Japan, (0.92%) by 
France and (0.74%) by the United States. The top 15 most productive countries relative citation index are more 
than the world average of 1 expect Egypt. 
Top 15 Authors Contributions in Hepatitis C 
Table 6 Top 15 Authors Contributions in Hepatitis C 
S. 
No 
Author Country Publications % 
Total 
Citations 
% CPP 
h-
Index 
RCI 
1 Zeuzem, S. Germany 355 11.56 28757 23.95 81.01 73 2.07 
2 Alavian, S.M. Iran 231 7.52 2546 2.12 11.02 26 0.28 
3 Chayama, K. Japan 224 7.29 6159 5.13 27.50 38 0.70 
4 Dore, G.J. Australia 207 6.74 9783 8.15 47.26 49 1.21 
5 Pol, S. France 205 6.68 9554 7.96 46.60 45 1.19 
6 Berg, T. Germany 203 6.61 10375 8.64 51.11 42 1.31 
7 Sarrazin, C. Germany 198 6.45 6398 5.33 32.31 41 0.83 
8 Chung, R.T. USA 196 6.38 6851 5.71 34.95 45 0.89 
9 Manns, M.P. Germany 196 6.38 9654 8.04 49.26 42 1.26 
10 Soriano, V. Spain 191 6.22 3797 3.16 19.88 32 0.51 
11 Colombo, M. Italy 185 6.02 1116 0.93 6.03 35 0.15 
12 Grebely, J. Australia 184 5.99 5764 4.80 31.33 39 0.80 
13 Wedemeyer, H. Germany 174 5.67 7246 6.03 41.64 42 1.07 
14 Forns, X. Spain 165 5.37 6828 5.69 41.38 38 1.06 
15 Younossi, Z.M. USA 157 5.11 5243 4.37 33.39 33 0.85 
From the table 6, identified that Zeuzem S., Germany contributed a maximum of 355 (11.56%) publications, 
followed by Alavian, S.M., Iran contributed  231(7.52%), Chayama K., Japan is  224 (7.29%). Based on the 
citation contribution maximum of Zeuzem S., Germany 28757(23.95%) citations, citation per paper is 81.01, h-
index is 73, and relative citation index is 2.07, followed by Berg T. 10375 (8.64%) citations with CPP is 51.11, h-
index is 42, RCI is 1.31.  Manns M.P., Germany 9654(8.04%) citations with Cpp is 49.26, h-index is 42, RCI is 
1.26. The RCI of top 15 authors is identified that 7 authors are greater than the world average and the remaining 8 
authors are below the world average. 
Top 15 Most Productive Journals  
Table 7 Top 15 Journals Contributions in Hepatitis C 
Name of the Journal Country 
No. of Publications Share of Publications Impact 
Factor 
(2017) 
2009-
2013 
2014-
2018 
2009-
2018 
2009-
2013 
2014-
2018 
2009-
2018 
Plos One United States 563 880 1443 1.94 2.84 2.39 2.766 
Hepatology United States 783 619 1402 2.70 2.00 2.35 14.049 
Journal Of Hepatology Netherland 620 584 1204 2.14 1.89 2.01 15.040 
Journal Of Viral Hepatitis UK 470 476 946 1.62 1.54 1.58 4.237 
World Jl of Gastroenterology China 329 450 779 1.13 1.45 1.29 3.300 
Liver International UK 310 420 730 1.07 1.36 1.21 4.500 
Gastroenterology UK 315 264 579 1.09 0.85 0.97 20.877 
Journal Of Virology United States 323 255 578 1.11 0.82 0.97 4.663 
Transplantation Proceedings United States 276 203 479 0.95 0.66 0.80 0.806 
Journal of Medical Virology United States 238 226 464 0.82 0.73 0.78 1.988 
Hepatitis Monthly Netherland 268 185 453 0.92 0.60 0.76 1.810 
Hepatology Research UK 207 239 446 0.71 0.77 0.74 3.418 
Alimentary Pharmacology & 
Therapeutics 
UK 142 274 416 0.49 0.89 0.69 7.357 
Clinical Infectious Diseases United States 172 241 413 0.59 0.78 0.69 9.117 
Liver Transplantation United States 261 152 413 0.90 0.49 0.70 3.752 
Others 23712 25469 49181 81.80 82.33 82.06 
 
Total World Publications 28989 30937 59926 
    
Top 15 most productive journals identified in table 7. During the study period maximum of contribution in the 
journal Plos One, United States is 1443 (2.39%) publications, followed by Hepatology; the United States is 1402 
(2.35%) publications, Journal of Hepatology, Netherland is 1204(2.01%). 
Top 15 Institutions Contribution in Hepatitis C 
Table 8 Top 15 Institutions Contribution in Hepatitis C 
Name of the 
Organizations 
Country Pub. % Citation % CPP h-Index RCI 
INSERM France 1826 17.35 55515 14.91 30.40 104 0.86 
AP-HP Assistance Publique  
- Hopitaux de Paris 
France 806 7.66 24306 6.53 30.16 80 0.85 
University of California, 
San Francisco 
United States 790 7.51 26624 7.15 33.70 71 0.95 
University of New South 
Wales UNSW Australia 
Australia 745 7.08 25116 6.75 33.71 63 0.95 
Harvard Medical School United States 718 6.82 29102 7.82 40.53 78 1.15 
VA Medical Center United States 707 6.72 26477 7.11 37.45 65 1.06 
National Institutes of 
Health, Bethesda 
United States 644 6.12 31212 8.39 48.47 80 1.37 
Cairo University Egypt 612 5.82 11567 3.11 18.90 34 0.53 
Massachusetts General 
Hospital 
United States 556 5.28 19179 5.15 34.49 70 0.98 
Hospital Clinic Barcelona Spain 549 5.22 22731 6.11 41.40 62 1.17 
Icahn School of Medicine 
at Mount Sinai 
United States 548 5.21 21924 5.89 40.01 70 1.13 
University of Toronto Canada 515 4.89 24276 6.52 47.14 59 1.33 
UniversitÃ  Degli Studi di 
Milano 
Italy 511 4.86 12843 3.45 25.13 59 0.71 
Centers for Disease Control 
and Prevention 
United States 500 4.75 19112 5.13 38.22 57 1.08 
UCL UK 495 4.70 22232 5.97 44.91 55 1.27 
Total 10522 100 372216 100 35.38 
  
During the study period top 15 institutions contribution is identified from table 8, From the study maximum of 
contribution by INSERM, France is 1826 (17.35%) publications with 55515 (14.91%) citations, 30.40 CPP, h-
index is 104, RCI is 0.86., followed by  AP-HP Assistance Publique - Hopitaux de Paris, France is 806(7.66%) 
publications with 24306 (6.53%) citations,  30.16 CPP, h-index is 80, RCI is 0.85. The third place is the 
University of California, San Francisco; the United States is 790(7.51%) publications with 26624 (7.15%) 
citations, 33.70CPP, h-index is 71, RCI is 0.95. The Relative Citation Index of top 15 institutions identified in 
that 8 institutions are greater than the world average and remaining 7 institutions are below the world average. 
Major Findings and Conclusion 
•    There are 59926 research publications are identified in hepatitis C during the study period, and maximum of 
6547 (10.93%) publications are contributed in the year 2015. 
•    The RGR has been decreasing trend from (0.71) in 2009 to (0.10) in 2018. Correspondingly the doubling time 
(Dt) has been increasing from 0.98 in 2010 to 7.28 in 2018. 
•    This study identified that a maximum of 41141 (68.65%) research publications are contributed by article and 
55746  (91.77%)research publications are the English language.  
•    From this study highest contribution share of 18160 (23.10%) publications with 460751 citations, CPP is 
25.37and RCI is 2.12 by the United States and expect Egypt top 15 most productive countries relative citation 
index is more than the world average. 
•    During the study it is identified that Zeuzem S., Germany contributed a maximum of 355 (11.56%) publications 
with 28757(23.95%) citations, citation per paper is 81.01, h-index is 73, and relative citation index is 2.07. 
•    During the study period maximum of 1443 (2.39%) publications in the journal of Plos One and the institution 
INSERM, France is 1826 (17.35%) publications with 55515 (14.91%) citations, 30.40 CPP, h-index is 104 
and RCI is 0.86.  
•    The overall ten year study period identified that the contributions of hepatitis C from SCOPUS database is 
average growth.  The disease is the biggest task to solve in this world to survive for the human begins, day by 
day the new infections are occupying in the human body. Hepatitis C is one of the types of disease that causes 
death worldwide. So this study concludes that must increase in the field of hepatitis C research in the world 
wild.    
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